Paul Cohen

Paul Cohen

Laboratory of Molecular Metabolism, The Rockefeller University

Affiliated withThe Rockefeller University

Research Area

Biography

Paul Cohen MD, PhD is the Albert Resnick, MD Assistant Professor and Head of the Laboratory of Molecular Metabolism at the Rockefeller University.

Dr. Cohen received his undergraduate degree from Harvard in 1996. He then entered the Tri-Institutional MD-PhD program, receiving his PhD in molecular genetics in 2003 from The Rockefeller University and his MD from Weill Cornell Medical College in 2004. He then completed clinical training in Internal Medicine at Columbia University Medical Center and in Cardiology at Brigham and Women’s Hospital.

He completed his postdoctoral research at Dana-Farber Cancer Institute and Harvard Medical School in Dr. Bruce Spiegelman’s laboratory. Dr. Cohen joined the faculty of Rockefeller in 2015 where his lab focuses on dissecting the mechanisms underpinning obesity-related diseases.

JoVE Journal Publications

ArticleTotal : 1
Year
Adipo-Clear: A Tissue Clearing Method for Three-Dimensional Imaging of Adipose Tissue
Publication title

Cited by 117

2018

Other Publications

Article
Year
Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells.

The Journal of experimental medicine| PubMed ID: 9705958

1998
2000
Selective deletion of leptin receptor in neurons leads to obesity.

The Journal of clinical investigation| PubMed ID: 11602618

2001
Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.

Science (New York, N.Y.)| PubMed ID: 12114623

2002
Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 12177411

2002
Stearoyl-CoA desaturase-1 and the metabolic syndrome.

Current drug targets. Immune, endocrine and metabolic disorders| PubMed ID: 14683458

2003
Site and mechanism of leptin action in a rodent form of congenital lipodystrophy.

The Journal of clinical investigation| PubMed ID: 14755338

2004
Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 15096593

2004
2004
Induction of leptin receptor expression in the liver by leptin and food deprivation.

The Journal of biological chemistry| PubMed ID: 15644325

2005
Cellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 18753616

2008
2015
The Multifaceted Roles of PRDM16: Adipose Biology and Beyond.

Trends in endocrinology and metabolism: TEM| PubMed ID: 26688472

2016
In Vitro Approaches to Model and Study Communication Between Adipose Tissue and the Liver.

Methods in molecular biology (Clifton, N.J.)| PubMed ID: 28244049

2017
Role of Perivascular Adipose Tissue in Vascular Physiology and Pathology.

Hypertension (Dallas, Tex. : 1979)| PubMed ID: 28320849

2017
2017
Adipose crosstalk with other cell types in health and disease.

Experimental cell research| PubMed ID: 28433698

2017
Insights into the Link Between Obesity and Cancer.

Current obesity reports| PubMed ID: 28434109

2017
Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes.

The Journal of clinical investigation| PubMed ID: 29083323

2017
2017
2018
2018